Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jonathan T. Blackmon"'
Autor:
Jonathan T. Blackmon, Michael S. Stratton, MD, Young Kwak, MD, Peter G. Pavlidakey, MD, Andrzej T. Slominski, MD, Svetlana B. McKee, RN, BSN, Toni M. Viator, RN, Ju Young Kim, PhD, Conway C. Huang, MD, Robert M. Conry, MD
Publikováno v:
JAAD Case Reports, Vol 3, Iss 4, Pp 280-283 (2017)
Externí odkaz:
https://doaj.org/article/9c7d8758102c4169a6e9450ef66bd8d3
Autor:
Jonathan T. Blackmon, Ratika Dhawan, MBBS, MPH, Toni M. Viator, RN, Nina L. Terry, MD, JD, Robert M. Conry, MD
Publikováno v:
JAAD Case Reports, Vol 3, Iss 3, Pp 185-189 (2017)
Externí odkaz:
https://doaj.org/article/17c56c06616340dfbffbe160641dff0b
Autor:
Young Kwak, Jonathan T. Blackmon, Michael Slade Stratton, Conway C. Huang, Toni M. Viator, Robert M. Conry, Peter G. Pavlidakey, Andrzej Slominski, Ju Young Kim, Svetlana B. McKee
Publikováno v:
JAAD Case Reports, Vol 3, Iss 4, Pp 280-283 (2017)
JAAD Case Reports
JAAD Case Reports
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60d426eefb11a6ebdbecdef0fae64a37
https://doi.org/10.1016/j.jdcr.2017.02.011
https://doi.org/10.1016/j.jdcr.2017.02.011
Publikováno v:
JAAD Case Reports
JAAD Case Reports, Vol 3, Iss 3, Pp 185-189 (2017)
JAAD Case Reports, Vol 3, Iss 3, Pp 185-189 (2017)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16d00d4621c241b8d9dbc1a5e760ce77
http://europepmc.org/articles/PMC5394182
http://europepmc.org/articles/PMC5394182
Publikováno v:
Melanoma research. 27(2)
Vemurafenib and dabrafenib, two Food and Drug Administration-approved selective BRAF kinase inhibitors (BRAFi), have revolutionized the targeted therapy of cutaneous melanoma. Off-target effects of these drugs paradoxically activate the MAP kinase pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b006326e7ab35d74f6e8be667f2c5e67
https://pubmed.ncbi.nlm.nih.gov/28252478
https://pubmed.ncbi.nlm.nih.gov/28252478